Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments(1)

Changes in serum adiponectin concentrations in critical illness: a preliminary investigation

Bala Venkatesh email, Ingrid Hickman email, Janelle Nisbet email, Jeremy Cohen email and John Prins email

Critical Care 2009, 13:R105doi:10.1186/cc7941



See related commentary by Owecki, http://ccforum.com/content/13/4/174

Statistical Concerns in Analysis of Adiponectin and Cortisol Data

Allan Walkey   (03 December 2009)  Boston University School of Medicine email

We read with interest the report by Venkatesh et al investigating changes in adiponectin during critical illness. Results show a significant relationship between adiponectin concentration and cortisol levels in critically ill subjects (eg., an R2 of 0.32 with p=0.01 at day 3). Upon further review of the data we observed that one extreme outlier exists in the cortisol day 3 data set (level 2620 nmol/L, with all other values below 600 nmol/L). As the authors point out, this outlier skews the cortisol data to a non-parametric distribution. Thus, in this case, the use of a simple linear regression to analyze the relationship between adiponectin and cortisol violates the normality assumptions needed for valid linear regression analyses. More appropriate analyses of these data would include reporting the Spearman correlation coefficient (as mentioned in Methods section) or log-transformation of the data for linear regression analysis. Performing these analyses, we found the Spearman correlation coefficient for the relationship between adiponectin and cortisol to be 0.51 with p=0.17; alternatively, linear regression with log-transformed values led to an R2=0.06 with p=0.33. Results demonstrate that when using non-parametric statistical methods, the relationship between adiponectin and cortisol at day 3 is no longer statistically significant. Despite this, we agree with the authors conclusion that “the relation between adiponectin and the inflammatory response, organ dysfunction and outcome in critical illness” is a subject worthy of future investigations.

Sincerely,

Allan Walkey, MD

Ross Summer, MD

Competing interests

We declare no competing interests.

top

Have something to say? Post a comment on this article!


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.